These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 30221197)

  • 1. Emerging Evidence for Cannabis' Role in Opioid Use Disorder.
    Wiese B; Wilson-Poe AR
    Cannabis Cannabinoid Res; 2018; 3(1):179-189. PubMed ID: 30221197
    [No Abstract]   [Full Text] [Related]  

  • 2. Medication Treatment of Opioid Use Disorder.
    Bell J; Strang J
    Biol Psychiatry; 2020 Jan; 87(1):82-88. PubMed ID: 31420089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabis use and opioid relapse: An exploratory survival analysis of prospectively collected data.
    Naji L; Rosic T; Sanger N; Dennis B; Hillmer A; Hudson J; Worster A; Paul J; Marsh DC; Thabane L; Samaan Z
    Front Psychiatry; 2022; 13():1046649. PubMed ID: 36465312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medications for Maintenance Treatment of Opioid Use Disorder in Adolescents: A Narrative Review and Assessment of Clinical Benefits and Potential Risks.
    Camenga DR; Colon-Rivera HA; Muvvala SB
    J Stud Alcohol Drugs; 2019 Jul; 80(4):393-402. PubMed ID: 31495374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of opioid withdrawal and initiation of medications for opioid use disorder in the hospital setting.
    Carswell N; Angermaier G; Castaneda C; Delgado F
    Hosp Pract (1995); 2022 Oct; 50(4):251-258. PubMed ID: 35837678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Buprenorphine use and disparities in access among emergency department patients with opioid use disorder: A cross-sectional study.
    Robbins M; Haroz R; Mazzarelli A; Clements D; Jones CW; Salzman M
    J Subst Abuse Treat; 2021 Nov; 130():108405. PubMed ID: 34118697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention and Treatment of Opioid Misuse and Addiction: A Review.
    Volkow ND; Jones EB; Einstein EB; Wargo EM
    JAMA Psychiatry; 2019 Feb; 76(2):208-216. PubMed ID: 30516809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medications for management of opioid use disorder.
    Koehl JL; Zimmerman DE; Bridgeman PJ
    Am J Health Syst Pharm; 2019 Jul; 76(15):1097-1103. PubMed ID: 31361869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Test of a workforce development intervention to expand opioid use disorder treatment pharmacotherapy prescribers: protocol for a cluster randomized trial.
    Molfenter T; Knudsen HK; Brown R; Jacobson N; Horst J; Van Etten M; Kim JS; Haram E; Collier E; Starr S; Toy A; Madden L
    Implement Sci; 2017 Nov; 12(1):135. PubMed ID: 29141653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing an opioid use disorder treatment cascade: A review of quality measures.
    Williams AR; Nunes EV; Bisaga A; Pincus HA; Johnson KA; Campbell AN; Remien RH; Crystal S; Friedmann PD; Levin FR; Olfson M
    J Subst Abuse Treat; 2018 Aug; 91():57-68. PubMed ID: 29910015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Opioid Treatments for Opioid Use Disorder: Rationales and Data to Date.
    Chalhoub RM; Kalivas PW
    Drugs; 2020 Oct; 80(15):1509-1524. PubMed ID: 32776315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid withdrawal symptoms, a consequence of chronic opioid use and opioid use disorder: Current understanding and approaches to management.
    Pergolizzi JV; Raffa RB; Rosenblatt MH
    J Clin Pharm Ther; 2020 Oct; 45(5):892-903. PubMed ID: 31986228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supervised Tablet Injectable Opioid Agonist Therapy (TiOAT): A Strategy to Address Safer Supply for Individuals With an Opioid Use Disorder?
    Weng J; Fairbairn N; Sutherland C; Johnson C; Nolan S
    J Addict Med; 2022 May-Jun 01; 16(3):258-260. PubMed ID: 34145188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale for cannabis-based interventions in the opioid overdose crisis.
    Lucas P
    Harm Reduct J; 2017 Aug; 14(1):58. PubMed ID: 28821296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review.
    Malta M; Varatharajan T; Russell C; Pang M; Bonato S; Fischer B
    PLoS Med; 2019 Dec; 16(12):e1003002. PubMed ID: 31891578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between cannabis use and patient outcomes in medication-based treatment of opioid use disorder: A systematic review.
    Lake S; St Pierre M
    Clin Psychol Rev; 2020 Dec; 82():101939. PubMed ID: 33130527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of Treatments for Opioid Use Disorder.
    Fairley M; Humphreys K; Joyce VR; Bounthavong M; Trafton J; Combs A; Oliva EM; Goldhaber-Fiebert JD; Asch SM; Brandeau ML; Owens DK
    JAMA Psychiatry; 2021 Jul; 78(7):767-777. PubMed ID: 33787832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between cannabis use and methadone maintenance treatment outcomes: an investigation into sex differences.
    Zielinski L; Bhatt M; Sanger N; Plater C; Worster A; Varenbut M; Daiter J; Pare G; Marsh DC; Desai D; MacKillop J; Steiner M; McDermid Vaz S; Thabane L; Samaan Z
    Biol Sex Differ; 2017; 8():8. PubMed ID: 28367308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Therapeutic Potential of Cannabidiol in Revolutionising Opioid Use Disorder Management.
    Le K; Au J; Hua J; Le KDR
    Cureus; 2023 Dec; 15(12):e50634. PubMed ID: 38226097
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.